Lifecore Biomedical Inc expected to post a loss of 35 cents a share - Earnings Preview

Lifecore Biomedical

27/08/2024 13:38

* Lifecore Biomedical Inc  LFCR.OQ   LFCR.O  is expected
to report
results for the period ending August 31 2024
    * The Chaska Minnesota-based  company is expected to report
revenue of $27.72 million, according to the estimate from one
analyst, based on LSEG data.
    * ​LSEG's mean analyst estimate for Lifecore Biomedical Inc
is for
a loss of 35 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts had fallen by
about 20.0%
in the last three months. ​
    * Wall Street's median 12-month price target for Lifecore
Biomedical Inc is $8.00​, above​ its last closing price
of $6.34. ​​​

This summary was machine generated August 27 at 12:38 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)